Advanced search

Vol 15, No 1 (2022)
Review paper
Published online: 2022-03-31

open access

View PDF Download PDF file
Page views 5546
Article views/downloads 786
Get Citation

Connect on Social Media

Connect on Social Media

Influence of chronic coffee consumption on the risk of kidney and other organ diseases. Review of the literature and clinical studies

Stanisław Surma1, Franciszek Kokot1
DOI: 10.5603/RDTF.2021.0015
Renal Disease and Transplantation Forum 2022;15(1):1-18.

Abstract

Due to its taste and biological properties, coffee has been a very popular drink for centuries. The average coffee consumption in Poland amounts to 3 kg per capita/year and systematically increases year by year. The most popular types of coffee grown in the world are Coffea arabica, Coffea canephora, and Coffea liberica. The biochemical composition of coffee depends on many factors, mainly the type of coffee and the method of its cultivation and production. Coffee contains over 1000 different chemical compounds, the most prevalent being caffeine, chlorogenic acid, trigonelline, kahweol, and cafestol. All of these compounds are characterized by high biological activity. A number of exogenous and endogenous factors affect the rate of caffeine metabolism, which may have important clinical implications. In addition, caffeine can interact with medications in various ways, increasing the risk of side effects. Numerous studies indicate both the beneficial and unfavorable effects of coffee consumption on human health. This review paper presents the effect of coffee consumption on the risk of developing diseases of the kidney, nervous system, digestive system, cardiovascular system, and metabolic diseases.

Keywords: coffeecardiovascular systemdigestive systemkidneysnervous system

Article available in PDF format

View PDF Download PDF file

References

  1. Romualdo GR, Rocha AB, Vinken M, et al. Drinking for protection? Epidemiological and experimental evidence on the beneficial effects of coffee or major coffee compounds against gastrointestinal and liver carcinogenesis. Food Res Int. 2019; 123: 567–589.
    CrossRefPubMed
  2. Surma S, Narkiewicz K. Kawa a ryzyko rozwoju nadciśnienia tętniczego i innych chorób układu krążenia. Choroby Serca i Naczyń. 2020; 17(1): 55–64.
    CrossRef
  3. https://kawa.pl/artykuly/kawa-w-liczbach-czyli-garsc-statystyk/. 30/3/2021.
  4. Lenart B. Na kawowym szlaku. Przegl Gastronom. 2006; 32(7-8): 32–8.
  5. Rubayiza AB, Meurens M. Chemical discrimination of arabica and robusta coffees by Fourier transform Raman spectroscopy. J Agric Food Chem. 2005; 53(12): 4654–4659.
    CrossRefPubMed
  6. Zgodka A, Lenart A. Wpływ składu surowcowego na właściwości mechaniczne kawy palonej mielonej. Inż Rol. 2005; 9: 419–427.
  7. Saw AC, Yam WS, Wong KC, et al. A comparative study of the volatile constituents of southeast Asian Coffea arabica, Coffea liberica and Coffea robusta green beans and their antioxidant activities. Journal of Essential Oil Bearing Plants. 2015; 18(1): 64–73.
    CrossRef
  8. Wintgens J. Factors influencing the quality of green coffee. In: Wintgens J. ed. Coffee: Growing, Processing, Sustainable Production. A Guidebook for Growers, Processors, Traders and Researchers. Wiley-VCH, Weinheim 2009: 797–817.
  9. Gonzalez de Mejia E, Ramirez-Mares MV. Impact of caffeine and coffee on our health. Trends Endocrinol Metab. 2014; 25(10): 489–492.
    CrossRefPubMed
  10. McCusker RR, Fuehrlein B, Goldberger BA, et al. Caffeine content of decaffeinated coffee. J Anal Toxicol. 2006; 30(8): 611–613.
    CrossRefPubMed
  11. Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018; 70(2): 384–411.
    CrossRefPubMed
  12. Lang R, Dieminger N, Beusch A, et al. Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal Bioanal Chem. 2013; 405(26): 8487–8503.
    CrossRefPubMed
  13. Stalmach A, Steiling H, Williamson G, et al. Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy. Arch Biochem Biophys. 2010; 501(1): 98–105.
    CrossRefPubMed
  14. Kuhn M, Lang S, Bezold F, et al. Time-resolved extraction of caffeine and trigonelline from finely-ground espresso coffee with varying particle sizes and tamping pressures. Journal of Food Engineering. 2017; 206: 37–47.
    CrossRef
  15. López-Galilea I, De Peña MP, Cid C. Correlation of selected constituents with the total antioxidant capacity of coffee beverages: influence of the brewing procedure. J Agric Food Chem. 2007; 55(15): 6110–6117.
    CrossRefPubMed
  16. Gross G, Jaccaud E, Huggett AC. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol. 1997; 35(6): 547–554.
    CrossRefPubMed
  17. Nieber K. The impact of coffee on health. Planta Med. 2017; 83(16): 1256–1263.
    CrossRefPubMed
  18. Díaz-Rubio ME, Saura-Calixto F. Dietary fiber in brewed coffee. J Agric Food Chem. 2007; 55(5): 1999–2003.
    CrossRefPubMed
  19. Lopes G, Ferreira A, Pinto M, et al. Carbohydrate content, dietary fibre and melanoidins: Composition of espresso from single-dose coffee capsules. Food Research International. 2016; 89: 989–996.
    CrossRef
  20. Fogliano V, Morales FJ. Estimation of dietary intake of melanoidins from coffee and bread. Food Funct. 2011; 2(2): 117–123.
    CrossRefPubMed
  21. de Melo Pereira GV, de Carvalho Neto DP, Magalhães Júnior AI, et al. Chemical composition and health properties of coffee and coffee by-products. Adv Food Nutr Res. 2020; 91: 65–96.
    CrossRefPubMed
  22. Wu L, Meng J, Shen Q, et al. Caffeine inhibits hypothalamic AR to excite oxytocin neuron and ameliorate dietary obesity in mice. Nat Commun. 2017; 8: 15904.
    CrossRefPubMed
  23. Ren Y, Wang C, Xu J, et al. Cafestol and kahweol: A review on their bioactivities and pharmacological properties. Int J Mol Sci. 2019; 20(17).
    CrossRefPubMed
  24. Marx B, Scuvée É, Scuvée-Moreau J, et al. [Mechanisms of caffeine-induced diuresis]. Med Sci (Paris). 2016; 32(5): 485–490.
    CrossRefPubMed
  25. Liszt KI, Ley JP, Lieder B, et al. Caffeine induces gastric acid secretion via bitter taste signaling in gastric parietal cells. Proc Natl Acad Sci U S A. 2017; 114(30): E6260–E6269.
    CrossRefPubMed
  26. Zuman W, Loh S, Esa N. Coffee and gastrointestinal health: a review. Malaysian Journal of Medicine and Health Sciences. 2019; 15: 96–103.
  27. Naveed M, Hejazi V, Abbas M, et al. Chlorogenic acid (CGA): A pharmacological review and call for further research. Biomed Pharmacother. 2018; 97: 67–74.
    CrossRefPubMed
  28. Higashi Y. Coffee and endothelial function: a coffee paradox? Nutrients. 2019; 11(9).
    CrossRefPubMed
  29. Peters BA, McCullough ML, Purdue MP, et al. Association of coffee and tea intake with the oral microbiome: results from a large cross-sectional study. Cancer Epidemiol Biomarkers Prev. 2018; 27(7): 814–821.
    CrossRefPubMed
  30. González S, Salazar N, Ruiz-Saavedra S, et al. Long-term coffee consumption is associated with fecal microbial composition in humans. Nutrients. 2020; 12(5).
    CrossRefPubMed
  31. Kim Y, Je Y, Giovannucci E. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur J Epidemiol. 2019; 34(8): 731–752.
    CrossRefPubMed
  32. Je Y, Giovannucci E. Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies. Br J Nutr. 2014; 111(7): 1162–1173.
    CrossRefPubMed
  33. Loftfield E, Cornelis MC, Caporaso N, et al. Association of coffee drinking with mortality by genetic variation in caffeine metabolism: Findings from the UK biobank. JAMA Intern Med. 2018; 178(8): 1086–1097.
    CrossRefPubMed
  34. Srithongkul T, Ungprasert P. Coffee consumption is associated with a decreased risk of incident chronic kidney disease: a systematic review and meta-analysis of cohort studies. Eur J Intern Med. 2020; 77: 111–116.
    CrossRefPubMed
  35. Kennedy OJ, Pirastu N, Poole R, et al. Coffee consumption and kidney function: A mendelian randomization study. Am J Kidney Dis. 2020; 75(5): 753–761.
    CrossRefPubMed
  36. Bigotte Vieira M, Magriço R, Viegas Dias C, et al. Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis. Nephrol Dial Transplant. 2019; 34(6): 974–980.
    CrossRefPubMed
  37. Lew QLJ, Jafar TH, Jin A, et al. Consumption of coffee but not of other caffeine-containing beverages reduces the risk of end-stage renal disease in the Singapore Chinese health study. J Nutr. 2018; 148(8): 1315–1322.
    CrossRefPubMed
  38. Caetano C, Valente A, Oliveira T, et al. Coffee consumption in hemodialysis patients: how many? Eur J Clin Nutr. 2019; 73(6): 924–929.
    CrossRefPubMed
  39. Wang S, Zhang Y, Mao Z, et al. A meta-analysis of coffee intake and risk of urolithiasis. Urol Int. 2014; 93(2): 220–228.
    CrossRefPubMed
  40. Ferraro PM, Cunha TD, Taylor EN, et al. Caffeine intake and the risk of kidney stones. Am J Clin Nutr. 2014; 100(6): 1596–1603.
    CrossRefPubMed
  41. Lohsiriwat S, Hirunsai M, Chaiyaprasithi B. Effect of caffeine on bladder function in patients with overactive bladder symptoms. Urol Ann. 2011; 3(1): 14–18.
    CrossRefPubMed
  42. Wijarnpreecha K, Thongprayoon C, Thamcharoen N, et al. Association between coffee consumption and risk of renal cell carcinoma: a meta-analysis. Intern Med J. 2017; 47(12): 1422–1432.
    CrossRefPubMed
  43. Wu W, Tong Y, Zhao Q, et al. Coffee consumption and bladder cancer: a meta-analysis of observational studies. Sci Rep. 2015; 5: 9051.
    CrossRefPubMed
  44. Hashemian M, Sinha R, Murphy G, et al. Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl Cancer Inst Monogr. 1985; 69(2): 229–234.
    PubMed
  45. Lipton RB, Diener HC, Robbins MS, et al. Caffeine in the management of patients with headache. J Headache Pain. 2017; 18(1): 107.
    CrossRefPubMed
  46. Jones HE, Herning RI, Cadet JL, et al. Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity. Psychopharmacology (Berl). 2000; 147(4): 371–377.
    CrossRefPubMed
  47. Couturier EG, Hering R, Steiner TJ. Weekend attacks in migraine patients: caused by caffeine withdrawal? Cephalalgia. 1992; 12(2): 99–100.
    CrossRefPubMed
  48. Alstadhaug KB, Andreou AP. Caffeine and primary (migraine) headaches-friend or foe? Front Neurol. 2019; 10: 1275.
    CrossRefPubMed
  49. Shirlow MJ, Mathers CD. A study of caffeine consumption and symptoms; indigestion, palpitations, tremor, headache and insomnia. Int J Epidemiol. 1985; 14(2): 239–248.
    CrossRefPubMed
  50. Liu QP, Wu YF, Cheng HY, et al. Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies. Nutrition. 2016; 32(6): 628–636.
    CrossRefPubMed
  51. Larsson SC, Orsini N. Coffee consumption and risk of dementia and Alzheimer's disease: a dose-response meta-analysis of prospective studies. Nutrients. 2018; 10(10).
    CrossRefPubMed
  52. Eskelinen MH, Ngandu T, Tuomilehto J, et al. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis. 2009; 16(1): 85–91.
    CrossRefPubMed
  53. Bragança M, Marinho M, Marques J, et al. The influence of espresso coffee on neurocognitive function in HIV-infected patients. AIDS Care. 2016; 28(9): 1149–1153.
    CrossRefPubMed
  54. Qi H, Li S. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatr Gerontol Int. 2014; 14(2): 430–439.
    CrossRefPubMed
  55. Hong CT, Chan L, Bai CH. The effect of caffeine on the risk and progression of Parkinson's disease: a meta-analysis. Nutrients. 2020; 12(6).
    CrossRefPubMed
  56. Clark I, Landolt HP. Coffee, caffeine, and sleep: A systematic review of epidemiological studies and randomized controlled trials. Sleep Med Rev. 2017; 31: 70–78.
    CrossRefPubMed
  57. Takabayashi A, Maruyama K, Tanno Y, et al. The association of coffee consumption and oxygen desaturation index during sleep among Japanese male workers. Sleep Breath. 2019; 23(4): 1027–1031.
    CrossRefPubMed
  58. Grosso G, Micek A, Castellano S, et al. Coffee, tea, caffeine and risk of depression: A systematic review and dose-response meta-analysis of observational studies. Mol Nutr Food Res. 2016; 60(1): 223–234.
    CrossRefPubMed
  59. Wang L, Shen X, Wu Y, et al. Coffee and caffeine consumption and depression: A meta-analysis of observational studies. Aust N Z J Psychiatry. 2016; 50(3): 228–242.
    CrossRefPubMed
  60. Song Y, Wang Z, Jin Y, et al. Association between tea and coffee consumption and brain cancer risk: an updated meta-analysis. World J Surg Oncol. 2019; 17(1): 51.
    CrossRefPubMed
  61. Cote DJ, Bever AM, Chiu YH, et al. A prospective study of tea and coffee intake and risk of glioma. Int J Cancer. 2020; 146(9): 2442–2449.
    CrossRefPubMed
  62. Godavarthy D, Naik R, Gali PK, et al. Can coffee combat caries? An study. J Oral Maxillofac Pathol. 2020; 24(1): 64–67.
    CrossRefPubMed
  63. Anila Namboodiripad Pc, Kori S. Can coffee prevent caries? J Conserv Dent. 2009; 12(1): 17–21.
    CrossRefPubMed
  64. Miranda J, Monteiro L, Albuquerque R, et al. Coffee is protective against oral and pharyngeal cancer: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2017; 22(5): e554–e561.
    CrossRefPubMed
  65. Kim J, Oh SW, Myung SK, et al. Korean Meta-analysis (KORMA) Study Group. Association between coffee intake and gastroesophageal reflux disease: a meta-analysis. Dis Esophagus. 2014; 27(4): 311–317.
    CrossRefPubMed
  66. Zheng JS, Yang J, Fu YQ, et al. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. Nutr Cancer. 2013; 65(1): 1–16.
    CrossRefPubMed
  67. Shimamoto T, Yamamichi N, Kodashima S, et al. No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. PLoS One. 2013; 8(6): e65996.
    CrossRefPubMed
  68. Li L, Gan Y, Wu C, et al. Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies. BMC Cancer. 2015; 15: 733.
    CrossRefPubMed
  69. Wijarnpreecha K, Thongprayoon C, Ungprasert P. Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017; 29(2): e8–ee12.
    CrossRefPubMed
  70. Kennedy OJ, Roderick P, Buchanan R, et al. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Aliment Pharmacol Ther. 2016; 43(5): 562–574.
    CrossRefPubMed
  71. Yu C, Cao Q, Chen P, et al. An updated dose-response meta-analysis of coffee consumption and liver cancer risk. Sci Rep. 2016; 6: 37488.
    CrossRefPubMed
  72. Godos J, Micek A, Marranzano M, et al. Coffee consumption and risk of biliary tract cancers and liver cancer: a dose-response meta-analysis of prospective cohort studies. Nutrients. 2017; 9(9).
    CrossRefPubMed
  73. Kennedy OJ, Roderick P, Buchanan R, et al. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis. BMJ Open. 2017; 7(5): e013739.
    CrossRefPubMed
  74. Zhang YP, Li WQ, Sun YL, et al. Systematic review with meta-analysis: coffee consumption and the risk of gallstone disease. Aliment Pharmacol Ther. 2015; 42(6): 637–648.
    CrossRefPubMed
  75. Li TD, Yang HW, Wang P, et al. Coffee consumption and risk of pancreatic cancer: a systematic review and dose-response meta-analysis. Int J Food Sci Nutr. 2019; 70(5): 519–529.
    CrossRefPubMed
  76. Zhou CD, Kuan AiS, Reeves GK, et al. Million Women Study Collaborators. Coffee and pancreatic cancer risk among never-smokers in the UK prospective Million Women Study. Int J Cancer. 2019; 145(6): 1484–1492.
    CrossRefPubMed
  77. Sartini M, Bragazzi NL, Spagnolo AM, et al. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective studies. Nutrients. 2019; 11(3).
    CrossRefPubMed
  78. Bae JM. Coffee consumption and colon cancer risk: A meta-epidemiological study of Asian cohort studies. Asian Pac J Cancer Prev. 2020; 21(5): 1177–1179.
    CrossRefPubMed
  79. Micek A, Gniadek A, Kawalec P, et al. Coffee consumption and colorectal cancer risk: a dose-response meta-analysis on prospective cohort studies. Int J Food Sci Nutr. 2019; 70(8): 986–1006.
    CrossRefPubMed
  80. Zhou A, Hyppönen E. Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases. Am J Clin Nutr. 2019; 109(3): 509–516.
    CrossRefPubMed
  81. D'Elia L, La Fata E, Galletti F, et al. Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies. Eur J Nutr. 2019; 58(1): 271–280.
    CrossRefPubMed
  82. Miranda AM, Goulart AC, Benseñor IM, et al. Coffee consumption and risk of hypertension: A prospective analysis in the cohort study. Clin Nutr. 2021; 40(2): 542–549.
    CrossRefPubMed
  83. van Oort S, Beulens JWJ, van Ballegooijen AJ, et al. Association of cardiovascular risk factors and lifestyle behaviors with hypertension: A mendelian randomization study. Hypertension. 2020; 76(6): 1971–1979.
    CrossRefPubMed
  84. Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, et al. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011; 94(4): 1113–1126.
    CrossRefPubMed
  85. Mostofsky E, Johansen MB, Lundbye-Christensen S, et al. Risk of atrial fibrillation associated with coffee intake: Findings from the Danish Diet, Cancer, and Health study. Eur J Prev Cardiol. 2016; 23(9): 922–930.
    CrossRefPubMed
  86. Bodar V, Chen J, Gaziano JM, et al. Coffee consumption and risk of atrial fibrillation in the physicians' health study. J Am Heart Assoc. 2019; 8(15): e011346.
    CrossRefPubMed
  87. Zuchinali P, Ribeiro PAB, Pimentel M, et al. Effect of caffeine on ventricular arrhythmia: a systematic review and meta-analysis of experimental and clinical studies. Europace. 2016; 18(2): 257–266.
    CrossRefPubMed
  88. Krittanawong C, Virk H, Farrell A, et al. Association between coffee consumption and risk of heart failure: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2018; 71(11): A865.
    CrossRef
  89. Mostofsky E, Rice MS, Levitan EB, et al. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ Heart Fail. 2012; 5(4): 401–405.
    CrossRefPubMed
  90. Wu Jn, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 2009; 137(3): 216–225.
    CrossRefPubMed
  91. Mo L, Xie W, Pu X, et al. Coffee consumption and risk of myocardial infarction: a dose-response meta-analysis of observational studies. Oncotarget. 2018; 9(30): 21530–21540.
    CrossRefPubMed
  92. Qian Yu, Ye D, Huang H, et al. Coffee consumption and risk of stroke: a mendelian randomization study. Ann Neurol. 2020; 87(4): 525–532.
    CrossRefPubMed
  93. Shao C, Tang H, Wang X, et al. Coffee consumption and stroke risk: vvidence from a Systematic Review and Meta-Analysis of more than 2.4 Million Men and Women. J Stroke Cerebrovasc Dis. 2021; 30(1): 105452.
    CrossRefPubMed
  94. Carlström M, Larsson SC. Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev. 2018; 76(6): 395–417.
    CrossRefPubMed
  95. Kim AnNa, Cho HJ, Youn J, et al. Coffee consumption, genetic polymorphisms, and the risk of type 2 diabetes mellitus: a pooled analysis of four prospective cohort studies. Int J Environ Res Public Health. 2020; 17(15).
    CrossRefPubMed
  96. Kondo Y, Goto A, Noma H, et al. Effects of coffee and tea consumption on glucose metabolism: a systematic review and network meta-analysis. Nutrients. 2018; 11(1).
    CrossRefPubMed
  97. Lee A, Lim W, Kim S, et al. Coffee intake and obesity: A meta-analysis. Nutrients. 2019; 11(6).
    CrossRefPubMed
  98. Cai L, Ma D, Zhang Y, et al. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2012; 66(8): 872–877.
    CrossRefPubMed
  99. Hallström H, Byberg L, Glynn A, et al. Long-term coffee consumption in relation to fracture risk and bone mineral density in women. Am J Epidemiol. 2013; 178(6): 898–909.
    CrossRefPubMed
  100. Li S, Dai Z, Wu Q. Effect of coffee intake on hip fracture: a meta-analysis of prospective cohort studies. Nutr J. 2015; 14: 38.
    CrossRefPubMed
  101. Machado-Fragua MD, Struijk EA, Ballesteros JM, et al. Habitual coffee consumption and risk of falls in 2 European cohorts of older adults. Am J Clin Nutr. 2019; 109(5): 1431–1438.
    CrossRefPubMed
  102. Moua ED, Hu C, Day N, et al. Coffee consumption and C-reactive protein levels: a systematic review and meta-analysis. Nutrients. 2020; 12(5).
    CrossRefPubMed
  103. Lyngsø J, Ramlau-Hansen CH, Bay B, et al. Association between coffee or caffeine consumption and fecundity and fertility: a systematic review and dose-response meta-analysis. Clin Epidemiol. 2017; 9(7): 699–719.
    CrossRefPubMed
  104. Kawanishi Y, Kakigano A, Kimura T, et al. Hypertensive disorders of pregnancy in relation to coffee and tea consumption: the Japan environment and children's study. Nutrients. 2021; 13(2).
    CrossRefPubMed
  105. Jeong G, Park SW, Lee YK, et al. Maternal food restrictions during breastfeeding. Korean J Pediatr. 2017; 60(3): 70–76.
    CrossRefPubMed
  106. Karabegović I, Portilla-Fernandez E, Li Y, et al. Epigenome-wide association meta-analysis of DNA methylation with coffee and tea consumption. Nat Commun. 2021; 12(1): 2830.
    CrossRefPubMed
  107. Rosenberg K. Meta-analysis shows coffee consumption is generally safe. Am J Nurs. 2018; 118(3): 69–70.
    CrossRefPubMed
  108. Semiz S, Serdarevic F. Prevention and management of type 2 diabetes and metabolic syndrome in the time of COVID-19: should we add a cup of coffee? Front Nutr. 2020; 7: 581680.
    CrossRefPubMed
  109. Temple JL. Caffeine use in children: what we know, what we have left to learn, and why we should worry. Neurosci Biobehav Rev. 2009; 33(6): 793–806.
    CrossRefPubMed
  110. Temple JL. Review: trends, safety, and recommendations for caffeine use in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2019; 58(1): 36–45.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Renal Disease and Transplantation Forum

About Via Medica Advertising
Bookstore (Ikamed) TVMed
News
Copyright © 2023 Via Medica Regulations Cookie policy Privacy policy Legal Notice